R
The startup develops therapies targeting the sympathetic nervous system to alleviate symptoms in patients with chronic bronchitis and emphysema. By reducing the impact of chronic obstructive pulmonary disease, the company enables patients to breathe more easily and improve their quality of life.
Mountain View, United States
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops therapies targeting the sympathetic nervous system to alleviate symptoms in patients with chronic bronchitis and emphysema. By reducing the impact of chronic obstructive pulmonary disease, the company enables patients to breathe more easily and improve their quality of life.